| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol.2019;25(1):42-51.   Published online November 19, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0029
                              Supplementary         Cited By 1
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Hyo Jun Ahn
Clin Mol Hepatol.2018;24(4):409-416.   Published online August 27, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0034
                                 Cited By 2
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol.2018;24(3):278-293.   Published online May 2, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1002
                              
Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis
Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki
Clin Mol Hepatol.2018;24(1):61-76.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0030
                              Supplementary      
Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
Dong Joon Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(2):115-122.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0018
                                 Cited By 3
Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
Gaeun Kim, Moon Young Kim, Soon Koo Baik
Clin Mol Hepatol.2017;23(1):34-41.   Published online March 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0059
                                 Cited By 16
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song
Clin Mol Hepatol.2016;22(4):499-502.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0016
                                 Cited By 7
Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach
Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2016;22(4):487-494.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0050
                                 Cited By 2
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding
Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam
Clin Mol Hepatol.2016;22(4):466-476.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0063
                                 Cited By 1
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0050
                                 Cited By 1
Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song
Clin Mol Hepatol.2016;22(2):259-266.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0020
                                 Cited By 5
Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song
Clin Mol Hepatol.2016;22(1):183-187.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.183
                                 Cited By 2
Magnetization-tagged MRI is a simple method for predicting liver fibrosis
Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna
Clin Mol Hepatol.2016;22(1):140-145.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.140
                              
Erectile dysfunction in patients with liver disease related to chronic hepatitis B
Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee
Clin Mol Hepatol.2015;21(4):352-357.   Published online December 24, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.4.352
                                 Cited By 6
What we know about paracentesis induced circulatory dysfunction?
Jeong Han Kim
Clin Mol Hepatol.2015;21(4):349-351.   Published online December 24, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.4.349
                              
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Clin Mol Hepatol.2014;20(4):384-391.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.384
                                 Cited By 21
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
Clin Mol Hepatol.2014;20(4):347-354.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.347
                                 Cited By 8
The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2014;20(1):47-55.   Published online March 26, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.1.47
                                 Cited By 1
Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
Hyung Ki Kim, Yoon Jun Kim, Woo Jin Chung, Soon Sun Kim, Jae Jun Shim, Moon Seok Choi, Do Young Kim, Dae Won Jun, Soon Ho Um, Sung Jae Park, Hyun Young Woo, Young Kul Jung, Soon Koo Baik, Moon Young Kim, Soo Young Park, Jae Myeong Lee, Young Seok Kim
Clin Mol Hepatol.2014;20(1):18-27.   Published online March 26, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.1.18
                                 Cited By 8
Management of portal hypertensive gastropathy and other bleeding
Woo Jin Chung
Clin Mol Hepatol.2014;20(1):1-5.   Published online March 26, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.1.1
                                 Cited By 2
Acute-on-chronic liver failure
Tae Yeob Kim, Dong Joon Kim
Clin Mol Hepatol.2013;19(4):349-359.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.349
                                 Cited By 32
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease
Heon Ju Lee, Myung Jin Oh
Clin Mol Hepatol.2013;19(2):179-184.   Published online June 27, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.2.179
                                 Cited By 4
Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis
Pei Chuan Tsung, Soo Hyung Ryu, In Hye Cha, Hee Won Cho, Jin Nam Kim, You Sun Kim, Jeong Seop Moon
Clin Mol Hepatol.2013;19(2):131-139.   Published online June 27, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.2.131
                                 Cited By 19
A case of variceal bleeding from the jejunum in liver cirrhosis
Chan Woong Park, Sae Hee Kim, Hyeon Woong Yang, Yun Jung Lee, Sung Hee Jung, Ho Sup Song, Sang Ok Lee, Anna Kim, Sang Woo Cha
Clin Mol Hepatol.2013;19(1):78-81.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.78
                                 Cited By 2
Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo, Jae Wan Lim, Hong Joo Kim, Yong Kyun Cho, Joo Hyun Sohn, Jae Yoon Jeong, Yu Hwa Lee, Tae Yeob Kim, Young Oh Kweon
Clin Mol Hepatol.2012;18(4):368-374.   Published online December 21, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.4.368
                                 Cited By 11
Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus
Seun Joo Ahn, Dong Kyu Kim, Soon Sun Kim, Chang Bum Bae, Hyo Jung Cho, Han Gyeol Kim, Young Jip Kim, Joo Ho Lee, Hyo Jin Lee, Mi Yeon Lee, Kee Bum Kim, Jin Hee Cho, Sung Won Cho, Jae Youn Cheong
Clin Mol Hepatol.2012;18(3):295-301.   Published online September 25, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.3.295
                                 Cited By 8
Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin
Clin Mol Hepatol.2012;18(3):287-294.   Published online September 25, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.3.287
                                 Cited By 8
Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
Eun Ju Cho, Su Hyeon Jeong, Byung Hoon Han, Sang Uk Lee, Byung Chul Yun, Eun Taek Park
Clin Mol Hepatol.2012;18(2):219-224.   Published online June 26, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.2.219
                                 Cited By 17
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol.2012;18(2):203-212.   Published online June 26, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.2.203
                                 Cited By 4
Revision and update on clinical practice guideline for liver cirrhosis
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang
Korean J Hepatol.2012;18(1):1-21.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.1
                                 Cited By 72
1 | 2 | 3 | 4 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 875
TOTAL : 67882